Stocktoria

Schrodinger, Inc. SDGR

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-02-06 · LEI

Schrodinger, Inc. statistics & valuation

Market cap$1.3B
P / S4.9×
P / B3.5×
P / FCF101.1×
Net margin-40.4%
Return on equity-28.4%
FCF margin4.9%
Return on capital-31.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-28.70% -22.60% -72.80% -82.40% 18.80% -90.20% -40.40% 2019202020212022202320242025
Gross margin (%)
57.40% 58.70% 47.60% 55.80% 64.90% 63.60% 55.70% 2019202020212022202320242025
Operating margin (%)
-45.30% -56.40% -80.80% -81.10% -81.90% -100.80% -65.20% 2019202020212022202320242025
Return on equity (%)
-3.90% -18.00% -33.30% 7.40% -44.40% -28.40% 2019202020212022202320242025
Shares outstanding
6.1M 60.7M 70.6M 71.2M 75.0M 72.7M 73.4M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-15.80% -3.30% -13.30% -21.70% 5.10% -22.70% -14.20% 2019202020212022202320242025
Free cash flow margin (%)
-32.60% 13.20% -56.40% -70.60% -69.30% -79.30% 4.90% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$0.41 -$1.42 -$2.10 $0.54 -$2.57 -$1.41 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin55.7%63.6%64.9%55.8%47.6%58.7%57.4%
Operating margin-65.2%-100.8%-81.9%-81.1%-80.8%-56.4%-45.3%
Net margin-40.4%-90.2%18.8%-82.4%-72.8%-22.6%-28.7%
FCF margin4.9%-79.3%-69.3%-70.6%-56.4%13.2%-32.6%
Return on assets-14.2%-22.7%5.1%-21.7%-13.3%-3.3%-15.8%
Return on equity-28.4%-44.4%7.4%-33.3%-18.0%-3.9%26.3%
Current ratio2.753.314.254.916.859.332.63

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.